Risk factors for allergic disease
Allan Linneberg
Research Centre for Prevention and Health, Glostrup University Hospital, the Capital Region of Copenhagen, Denmark
28.Sep.2012
16 min.
Early life development of the immune system
Susan L. Prescott
University of Western Australia, School of Paediatrics and Child Health,
Princess Margaret Hospital, Perth, Australia
28.Sep.2012
20 min.
Allergic diseases and gene-environment interactions
Erika von Mutius
Asthma and Allergy Department, University Children's Hospital,
Munich, Germany
28.Sep.2012
15 min.
The role of the dendritic cells in allergy and immunotherapy
Natalija Novak and Jean-Pierre Allam
Department of Dermatology and Allergy, University of Bonn,
Germany
28.Sep.2012
18 min.
The role of the basophil in allergic disease
Bernhard F Gibbs
Medway School of Pharmacy, University of Kent,
Chatham Maritime, United Kingdom
28.Sep.2012
18 min.
The role of the IgE repertoire in allergic disease
Lars H Christensen
CMC Research, ALK, Hørsholm, Denmark
28.Sep.2012
17 min.
Mechanisms of T-cell activation versus tolerance
David C Wraith
University of Bristol,
Bristol, United Kingdom
28.Sep.2012
15 min.
Natural course of house dust mite allergy
Thomas AE Platts-Mills
Asthma and Allergic Disease Center, University of Virginia,
Virginia, United States
28.Sep.2012
18 min.
Allergen avoidance in house dust mite allergy
Susanne Lau
Department of Paediatric Pneumology and Immunology,
Charité Medical University Berlin, Berlin, Germany
28.Sep.2012
15 min.
Treatment of house dust mite allergy
Jean Bousquet
University Hospital Montpellier,
Montpellier, France
28.Sep.2012
15 min.
Guidelines for the management of anaphylaxis
F Estelle R Simons
University of Manitoba, Manitoba,
Winnipeg, Canada
28.Sep.2012
23 min.
Development and implementation of national anaphylaxis guidelines
Tomás Chivato
School of Medicine, CEU San Pablo University,
Madrid, Spain
28.Sep.2012
10 min.
Engaging adolescents and young adults at risk of anaphylaxis
Graham C Roberts
Allergy and Respiratory Medicine, University of Southampton,
Southampton, United Kingdom
28.Sep.2012
13 min.
Optimising adrenaline administration
Anthony J Frew
Dept. of Respiratory Medicine, Royal Sussex County Hospital,
Brighton, United Kingdom
29.Sep.2012
17 min.
Allergen avoidance in house dust mite allergy
Ulrich Wahn
Department of Paediatric Pneumology and Immunology, Charité,
Berlin, Germany
29.Sep.2012
15 min.
Primary prevention of allergic disease
Patrick G Holt
Telethon Institute for Child Health Research,
University of Western Australia, Perth, Australia
29.Sep.2012
19 min.
Secondary prevention of allergic disease
Adam T Fox
Guy's & St Thomas' Hospitals, NHS Foundation Trust,
London, United Kingdom
29.Sep.2012
17 min.
The first four years of the Finnish allergy programme 2008-2018
Tari Haahtela, Erkka Valovirta, Erja Tommila, Mika J Mäkelä, and the Finnish Allergy Programme Committee
Skin and Allergy Hospital, Helsinki University Hospital,
Helsinki, Finland
29.Sep.2012
19 min.
Mechanisms of allergen immunotherapy
Stephen R Durham
Section of Allergy and Clinical Immunology,
National Heart and Lung Institute, Imperial College London,
London, United Kingdom
29.Sep.2012
21 min.
Safety and efficacy of ragweed allergy immunotherapy tablets
Hendrik Nolte
Allergy/Respiratory Diseases, Merck Research Laboratories, Merck Inc., New Jersey, United States
29.Sep.2012
16 min.
Efficacy of immunotherapy and symptomatic drugs
Paolo M Matricardi
Dept. of Paediatric Pneumology and Immunology, Charité Medical School, Berlin, Germany
29.Sep.2012
16 min.
Dogmas, fallacies and misconceptions regarding allergen specific immunotherapy
Pascal Demoly¹ and Moisés A Calderón²
University Hospital of Montpellier - Inserm U657 - EA2415, Montpellier, France Section of Allergy and Clinical Immunology, Imperial College, NHLI, Royal Brompton Hospital, London, United Kingdom
29.Sep.2012
20 min.
Immunotherapy beyond the niche
Henrik Jacobi
Research & Development, ALK, Hørsholm, Denmark
29.Sep.2012
15 min.
